Horizons Ventures led a $23m Series B funding round in Syzygy Plasmonics.

Horizons Ventures, a venture capital firm, led a $23m Series B funding round in Syzygy Plasmonics, a technology company developing the world’s highest performance photocatalyst for the industrial gas, chemical and energy industries. The round had participation from investors Equinor Ventures, The Engine, GOOSE Capital and Evok Innovations. “With renewable electricity as an energy source, our technology is cleaner, and because of the stability and activity of our photocatalysts, we can drive dozens of possibilities, tuning reactions that produce different chemicals. Our initial product will focus on eliminating emissions from hydrogen production, transforming the industrial process involved in making semiconductors, LEDs and metals. Our system will also enable industries that are consumers of hydrogen fuel cells, like fuel cell vehicles," Trevor Best, Syzygy Plasmonics Co-Founder and CEO.